跳转至内容
Merck

T2577

Sigma-Aldrich

替莫唑胺

≥98% (HPLC), powder, DNA methylating agent

别名:

3,4-二氢-3-甲基-4-氧代咪唑并[5,1-d]-1,2,3,5-四嗪-8-甲酰胺, 3-甲基-4-氧代-3,4-二氢咪唑并[5,1-d][1,2,3,5]四嗪-8-甲酰胺, 4-甲基-5-氧代-2,3,4,6,8-五氮杂双环[4.3.0]壬基-2,7,9-三烯-9-甲酰胺, 8-氨甲酰-3-甲基咪唑[5,1-d]-1,2,3,5-四嗪-4(3H)-酮, NSC 362856

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C6H6N6O2
CAS号:
分子量:
194.15
MDL號碼:
分類程式碼代碼:
12352200
PubChem物質ID:
NACRES:
NA.77

产品名称

替莫唑胺, ≥98% (HPLC)

化驗

≥98% (HPLC)

形狀

powder

顏色

white to light brown

溶解度

DMSO: 10 mg/mL, clear
H2O: insoluble

起源

Schering Plough

儲存溫度

2-8°C

SMILES 字串

CN1N=Nc2c(ncn2C1=O)C(N)=O

InChI

1S/C6H6N6O2/c1-11-6(14)12-2-8-3(4(7)13)5(12)9-10-11/h2H,1H3,(H2,7,13)

InChI 密鑰

BPEGJWRSRHCHSN-UHFFFAOYSA-N

正在寻找类似产品? 访问 产品对比指南

一般說明

替莫唑胺(Temozolomide)是一种小分子的亲脂性烷化剂。在DNA中与亲核微环境(鸟嘌呤残基)产生共价作用,因此替莫唑胺具有细胞毒性。替莫唑胺的作用机制是通过水解DNA,导致DNA降解并破坏肿瘤细胞。替莫唑胺对恶性神经胶质瘤细胞的主要作用是令G2/ M细胞周期停滞,偶尔使细胞凋亡。替莫唑胺是一种DNA甲基化剂和耐药修饰剂;抗肿瘤和抗血管生成。替莫唑胺诱导G2/M阻滞和凋亡,原理是其通过基因组DNA中一个甲基基团内收至鸟嘌呤的O6位置,以及碱基切除修复(BER)途径中DNA修复蛋白O(6)-烷基鸟嘌呤DNA烷基转移酶(AGT)的功能失活。

應用

替莫唑胺已用于分析胶质母细胞瘤细胞系的耐药机制。替莫唑胺已用于诱导胶质母细胞瘤细胞的细胞毒性作用,以研究蛋白二硫化物异构酶(PDI)的抑制作用。

生化/生理作用

替莫唑胺是一种DNA甲基化剂和耐药修饰剂;抗肿瘤和抗血管生成。替莫唑胺诱导G2/M阻滞和凋亡,原理是其通过基因组DNA中一个甲基基团内收至鸟嘌呤的O6位置,以及碱基切除修复(BER)途径中DNA修复蛋白O(6)-烷基鸟嘌呤DNA烷基转移酶(AGT)的功能失活。

特點和優勢

该化合物是细胞凋亡研究的推荐产品。点击此处了解更多特色细胞凋亡产品。在sigma.com/discover-bsm 上了解有关生物活性小分子在其他研究领域的更多信息。
该化合物由 Schering Plough开发。要浏览其他药物开发的化合物和已批准药物/候选药物的列表,请单击此处

準備報告

替莫唑胺溶于DMSO,溶解浓度大于20 mg/ml。它不溶于水。

象形圖

Health hazardExclamation mark

訊號詞

Danger

危險分類

Acute Tox. 4 Oral - Carc. 1B - Eye Irrit. 2 - Muta. 1B - Repr. 1B - Skin Irrit. 2 - STOT SE 3

標靶器官

Respiratory system

儲存類別代碼

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

水污染物質分類(WGK)

WGK 3

個人防護裝備

Eyeshields, Gloves, type P3 (EN 143) respirator cartridges


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Charly Helaine et al.
Cancers, 12(12) (2020-12-04)
(1) We wanted to assess the impact of Ang2 in RCT-induced changes in the environment of glioblastoma. (2) The effect of Ang2 overexpression in tumor cells was studied in the GL261 syngeneic immunocompetent model of GB in response to fractionated
Antonin Dréan et al.
Journal of neuro-oncology, 138(3), 479-486 (2018-03-10)
ATP-binding cassette transporters (ABC transporters) regulate traffic of multiple compounds, including chemotherapeutic agents, through biological membranes. They are expressed by multiple cell types and have been implicated in the drug resistance of some cancer cells. Despite significant research in ABC
Keith A Menear et al.
Journal of medicinal chemistry, 51(20), 6581-6591 (2008-09-20)
Poly(ADP-ribose) polymerase activation is an immediate cellular response to metabolic-, chemical-, or ionizing radiation-induced DNA damage and represents a new target for cancer therapy. In this article, we disclose a novel series of substituted 4-benzyl-2 H-phthalazin-1-ones that possess high inhibitory
Julien Hadoux et al.
International journal of cancer, 135(11), 2711-2720 (2014-04-23)
Cyclophosphamide-dacarbazine-vincristine regimen is recommended for the treatment of malignant pheochromocytoma and paraganglioma (MPP); however, dacarbazine is the only recognized active drug in neuroendocrine tumours. We investigated the therapeutic benefit of temozolomide (TMZ), an oral alternative to dacarbazine, in patients with
Olivier L Chinot et al.
The New England journal of medicine, 370(8), 709-722 (2014-02-21)
Standard therapy for newly diagnosed glioblastoma is radiotherapy plus temozolomide. In this phase 3 study, we evaluated the effect of the addition of bevacizumab to radiotherapy-temozolomide for the treatment of newly diagnosed glioblastoma. We randomly assigned patients with supratentorial glioblastoma

商品

We presents an article on Autophagy in Cancer Promotes Therapeutic Resistance

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门